Invention Grant
- Patent Title: Method for the diagnosis or prognosis, in vitro, of lung cancer
-
Application No.: US14367872Application Date: 2012-12-20
-
Publication No.: US11519042B2Publication Date: 2022-12-06
- Inventor: Philippe Perot , François Mallet , Cécile Montgiraud , Nathalie Mugnier
- Applicant: BIOMERIEUX
- Applicant Address: FR Marcy l'Etoile
- Assignee: BIOMERIEUX
- Current Assignee: BIOMERIEUX
- Current Assignee Address: FR Marcy l'Etoile
- Agency: Oliff PLC
- Priority: FR11/62089 20111220
- International Application: PCT/FR2012/053012 WO 20121220
- International Announcement: WO2013/093353 WO 20130627
- Main IPC: C12Q1/70
- IPC: C12Q1/70 ; C12Q1/6886 ; G01N33/574
Abstract:
The subject matter of the present invention is a method for the diagnosis or prognosis, in vitro, of lung cancer, which includes a step of detecting at least one expression product of at least one HERV nucleic acid sequence, a method for use of said nucleic acid sequences, which have been isolated, as a molecular marker or molecular markers, and a kit including at least one binding partner specific for at least one of the expression products of the HERV nucleic acid sequences.
Public/Granted literature
- US20150119265A1 METHOD FOR THE DIAGNOSIS OR PROGNOSIS, IN VITRO, OF LUNG CANCER Public/Granted day:2015-04-30
Information query
